Ticker Launch
Sign inTry it free

SPAC · Merger completed

OTR Acquisition Corp.

Business combination with Comera Life Sciences, Inc.

OTR Acquisition Corp. is a blank-check company (SPAC) that raised $100M in its initial public offering on Nov 19, 2020, listing on Nasdaq Capital Market. It completed its business combination with Comera Life Sciences, Inc. on May 19, 2022; the combined company is Comera Life Sciences Holdings, Inc. (CMRA). Ellenoff Grossman & Schole advised the SPAC and Loeb & Loeb advised the underwriters on the IPO.

Comera Life Sciences applies formulation science to convert biologic medicines from intravenous to subcutaneous forms through its proprietary SQore platform, aiming to let patients self-inject and reduce reliance on institutions.

Status
Merger completed
IPO date
Nov 19, 2020
IPO size
$100M
IPO exchange
Nasdaq Capital Market
Target
Comera Life Sciences, Inc.
Announced
Feb 4, 2022
Closed
May 19, 2022
Combined company
Comera Life Sciences Holdings, Inc. (CMRA)
SPAC counsel (IPO)
Ellenoff Grossman & Schole
Underwriters' counsel (IPO)
Loeb & Loeb

More on this SPAC for subscribers

Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.

Try it free for 7 daysOpen in Ticker Launch

Then $99/month or $999/year. Cancel anytime.

Filings

Other deSPACs that closed in 2022